Remove 2025 Remove Degenerative Disc Disease Remove Musculoskeletal
article thumbnail

Groundbreaking Spine Surgery Performed by Dr. Ehsan Jazini Marks New Era in Motion-Preserving Procedures

OrthoSpineNews

First in the Nation to Perform Custom Combination of prodisc® C Nova and prodisc® C VIVO Disc Replacement. June 25, 2025 /PRNewswire/ — VSI® proudly announces a groundbreaking achievement in spine surgery, led by nationally recognized spine surgeon Dr. Ehsan Jazini. RESTON, Va.,

article thumbnail

Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration

OrthoSpineNews

Data readout expected in Q1 2026 MIAMI, July 29, 2025 (GLOBE NEWSWIRE) — Vivex Biologics, Inc., Its current therapies help patients suffering from chronic lower back pain, musculoskeletal injuries, wounds and burns.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine

OrthoSpineNews

July 8, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. Companion Spine is a portfolio company of Viscogliosi Brothers, LLC, a family-owned investment firm specializing in the neuro-musculoskeletal space. The transaction is expected to close in the third quarter of 2025. The proceeds of the transaction total $19.2

article thumbnail

Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion 

OrthoSpineNews

The results will be presented at the American Society of Pain and Neuroscience (ASPN) annual conference in July 2025, spotlighting Aurora Spines commitment to evidence-based innovation. CARLSBAD, Calif., CARLSBAD, Calif., As an orthopedic surgeon, I see firsthand the need for reliable, minimally invasive solutions.

article thumbnail

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

OrthoSpineNews

June 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. This data was shared at the prestigious ISSCR 2025 Annual Meeting in Hong Kong by Francisco Silva, Vice President of Research and Development. We have also obtained U.S.